Archean Chemical Industries Ltd Q3 FY2025 Concall Summary

Key Takeaways

• Challenging quarter, partial recovery emerging: Macro headwinds, oversupply and weather disruptions compressed realizations and volumes, but management sees an uptick in demand and pricing post Chinese New Year.
• Bromine business is the bright spot: Demand remains healthy with a pricing uptick underway, and captive consumption is set to jump from ~5% to over 20% next year as the derivatives plant ramps up.
• Salt volumes are the near-term swing factor: Logistical disruptions that crushed dispatches are now largely resolved; management is optimistic about hitting a 0.1–0.12 crore ton run rate in coming quarters.
• Semiconductor ambition is real but unquantified: Ground has been broken on the SiCSem facility, but management declined to share peak revenue, margin projections or the final debt-equity mix, deferring answers until central government subsidy clarity arrives.
• What to watch next quarter: Whether the promised salt volume recovery materializes, the pace of bromine derivatives revenue ramp, and any concrete numbers on the semiconductor financing mix.

Demand & Pricing Environment

• Global macro overhang: Sluggish consumption in the US, China and Europe, combined with oversupply of certain raw materials and aggressive pricing from major suppliers, kept average realizations under pressure through the quarter.
• Partial recovery underway: Management flagged an uptick in both demand and pricing as of the call date, with a more pronounced recovery expected post Chinese New Year.
• Weather disruptions receding: Slack in supply chains and logistics from the previous quarter and part of last quarter is largely behind the company; logistics performance improved this quarter.
• Bromine pricing tailwind: A combination of rupee depreciation improving export realizations, past dollar-denominated contracts benefiting from currency moves, and higher pricing on certain rupee transactions in the Indian market drove an uptick.
• Agrochem muted but hopeful: The sector was not strong last quarter; the company maintained share in a subdued environment and expects revival later this quarter and definitely by Q1 next financial year.

Pendurthi: "I think it's good that ICL is pushing more volume, which means the market is healthy, right, and it really absorbs. So, it only comes down to how much more we can make."

Bromine & Derivatives

• Elemental bromine demand intact: The company has never struggled to sell bromine; backlog indicates offtake remains healthy with no let-up on the demand side.
• Conservative volume guidance: Management expects to produce nearly 20,000 to 25,000 tons of bromine in FY '26, including captive consumption, and will review whether to maintain or upgrade that estimate two quarters into next year.
• Captive consumption inflection: Currently at ~5% to 7% of bromine output, captive use is expected to exceed ~20% to 25% next full year as the Acume derivatives plant ramps up.
• Acume ramp progressing: The bromine derivatives plant is ramping steadily; meaningful revenue growth is anticipated in FY '26.
• Clear brine fluids in trial phase: A few trial shipments have been dispatched; approval from oil and gas procurement departments is slower due to technical specifications, but management is confident trials will be accepted and quantities will improve.
• Customer base diversification: The company is adding more customers and spreading material to ensure a more diversified customer base in the years to come.

Pendurthi: "I think we continue to give a conservative estimate because we would like to ensure that we are able to deliver. I think two quarters in to the next year we possibly will have a chance to review that number and see if we need to maintain it or upgrade it."

Salt & SOP

• Salt logistics ironed out: Mobilization and transport challenges that plagued the previous quarter were resolved over the last month or so toward quarter-end; volumes are expected to pick up this quarter and coming quarters.
• Run rate ambition: Management is optimistic about achieving a 0.1 crore to 0.12 crore ton run rate in coming quarters.
• Salt contract pricing reset: New contract pricing will be a bit below last year's, but some contracts are C&F, so the company may gain on freight given moderated oil prices; on a contribution basis, management will endeavor to maintain.
• SOP trials progressing: Pilot runs and trials are targeted pre-monsoon, which is the best time to test; ramp-up will start post-monsoon in the dry season, with meaningful contribution expected thereafter.
• SOP volume target uncommitted: Management declined to commit to a 20,000-ton number, but said that would ideally be a reasonable number to expect.
• June '24 quarter not repeatable soon: Management does not anticipate hitting anywhere near that quarter's volume levels in coming quarters, though volumes have picked up over the last couple of months on both bromine and salt.

Oren Hydrocarbon & Other Verticals

• Oren Hydrocarbon restart plan: Acquired through the NCLT route in July 2024; refurbishment takes time; the plan is to restart two units this quarter with two more in coming months; order inquiries look promising.
• PTA synthesis steady: Demand remains steady, supported by growth in textiles and packaging industries; good opportunities as polymer consumption increases.
• Flame retardant strategy reset: Dialogue on technology transfer has restarted; the company wants flexibility with pricing and will not tie into a buy-back arrangement; any long-term contracts would be with end users, not intermediate players.

Semiconductor & New Ventures

• SiCSem groundbreaking complete: The groundbreaking of the semiconductor facility took place at the Utkarsh Odisha conclave in end-January 2025; land is allotted and the company is moving into local permissions for construction.
• Total investment ~Rs. 3,000 crores: The company will eventually invest about Rs. 3,000 crores in the compound semiconductor facility through subsidiary SiCSem Private Limited.
• Timeline 24–30 months from shovel to ground: Once construction begins, the project timeline is 24 to 30 months; a clearer update is expected possibly next quarter as pieces are put together over the next few months.
• Financing mix unanswered: Management declined to specify how much debt would be taken, deferring the answer until clarity arrives from the central government's Indian Semiconductor Mission on subsidies; the state government is 100% behind the project.
• Peak revenue and margins undisclosed: Management said it is not ready to share peak revenue or margin projections for the semiconductor business, but pushed back on the assumption that capital-intensive means low-margin, citing Archean's own history of delivering healthy margins on a high-CAPEX chemical project.
• Clas-SiC investment for process know-how: The strategic investment in Clas-SiC Wafer Fab Limited (UK) provides technology and process know-how under a licensing royalty and consulting agreement; SiCSem is solely responsible for what products to make and is not bound by any agreement with anyone.
• Offgrid Energy Labs investment: The company committed a total investment of \$12 million in Offgrid Energy Labs Inc (zinc bromide battery technology); a two-year roadmap is in place for a pilot plant set up in the UK, with a factory in India to be considered after the pilot.
• Semiconductor first to revenue: The semiconductor project is anticipated to come first from a commercial revenue generation perspective, ahead of Offgrid Energy.

Pendurthi: "We probably, irrespective of the size, we are I think the only ones who ventured and made our investment in a compound semiconductor fab overseas. Albeit small, but the size is not the important thing, the process know-how and the capability of the Company invested, that's the most important thing in the semiconductor business."

Balance Sheet & Capital Allocation

• Net debt free: The company continues to remain net debt free with a strong balance sheet.
• Near-term CAPEX light: Over the next six months to a year, no big capital commitments are planned; semiconductor may see some groundwork, civil work and advances on equipment, but no large CAPEX is planned at the moment.
• Promoter share pledge: Management stated the pledge is not connected to Archean Chemicals' business and serves funding requirements, but did not specify what the funding is for.
• Lease renewal awaiting approval: Work is in progress with no fresh update; to management's knowledge, other companies are also waiting.

Guidance & Commitments

Key Metrics